Wisam F.doc J Bagh College Dentistry Vol. 28(2), June 2016 Salivary calcium binding Pedodontics, Orthodontics and Preventive Dentistry 149 A Salivary Calcium Binding Protein in Patients with Oral Squamous Cell Carcinoma in Relation to Smoking Wisam Hamid Edan, B.D.S., M.Sc. (1) Sulafa Khalid El-Samarrai, B.D.S., M.Sc., Ph.D. (2) ABSTRACT Background: Calcium binding protein regulates many important cellular functions such as cell proliferation, cell motility and differentiation. Over-expression of calcium BP was detected in different human cancers, including oral squamous cell carcinoma (OSCC). Therefore the aim of the present study was to evaluate the role of calcium binding protein in OSCC, quantified in stimulated saliva, and its association with smoking. Materials and methods: The present study included 20 patients with oral squamous cell carcinoma who used to be smokers, and 40 control subjects. Calcium binding protein was assessed by ELISA technique, in stimulated saliva collected from all groups. Results: Salivary calcium binding protein was significantly higher in smoker patients with oral squamous cell carcinoma than smoker and non- smoker control healthy looking subjects. Conclusions: Salivary calcium binding protein play a significant role, as a non-invasive approach, in the early diagnosis and follow up of oral squamous cell carcinoma patients. Key words: OSCC, calcium binding protein, saliva, smoking. (J Bagh Coll Dentistry 2016; 28(2):149-151). INTRODUCTION The chronologic sequence of histologic stages of oral squamous cell carcinoma includes the transition from benign hyperplasia to dysplasia to carcinoma in-situ, and then ultimately followed by invasive squamous cell carcinoma. This phenotypic alteration is the results of multistep genetic mutations and altered gene expression (1,2). Tobacco is claimed to be one of the major environmental carcinogenic agents that are responsible for such mutations (3,4). Analysis of saliva proteins, a non-invasive substitute to tissue biopsy, from patients with OSCC is a promising approach for diagnosis, monitoring and therapeutic targeting The S100 proteins are a multi- gene calcium-binding family, comprising more than 20 different proteins which are encoded by a separate gene and are expressed in a controlled tissue specific or cell type-specific manner (7). They are small, acidic proteins of 10-12 KDa and form the largest family of calcium binding proteins. They regulate many important cellular functions such as cytoskeleton organization, homeostasis, stress response, cell proliferation, cell motility and differentiation (8). Over-expression of calcium protein was detected in different human cancers, presenting increased expression in neoplastic tumor cells as well as infiltrating immune cells (9-12). S100 A9 over-expression was also reported in oral squamous cell carcinoma (OSCC) (13). (1)Ph.D. student. Department of Pedodontics and Preventive Dentistry, College of Dentistry, University of Baghdad. (2)Professor. Department of Pedodontics and Preventive Dentistry, College of Dentistry, University of Baghdad. Thus the aim of the present study was to evaluate the role of calcium binding protein in OSCC, quantified in stimulated saliva, and its association with smoking. SUBJECTS, MATERIALS AND METHOD The present study included 20 patients with oral squamous cell carcinoma who used to be smokers. For the purpose of comparison, 20 apparently healthy smokers and another 20 non- smokers were enrolled. Control subjects were chosen in such a way to be matched with age and gender of the patients. Patients age was from 40 to 70 years, included (8) females and (12) males. The study was conducted in Ghazi Al-Hariri hospital, Al-Yarmook teaching Hospital and Al- Kadhimiya teaching hospital in Baghdad. The study was held from October 2014 through February 2015. From each patient and control subjects a sample of stimulated saliva (400^L) was obtained between 8:00 am and 11:00 am. Saliva was stored at -80C° till the time of analysis. Calcium binding protein was assessed by ELISA (Elabscience; China) Statistical analysis was performed using SPSS version 16. Being a non -normally distributed variable, comparison of mean calcium binding concentration among groups was done using the non-parametric Kruskal Wallis test and Mann Whitney U test. P-value was considered significant when it was less than or equal to 0.05 and highly significant when it was less than or equal to 0.001. J Bagh College Dentistry Vol. 28(2), June 2016 Salivary calcium binding Pedodontics, Orthodontics and Preventive Dentistry 150 RESULTS Median values of calcium BP level was significantly higher in smoker patients in comparison to other two groups (P <0.001), as shown in Table 1 and Figure 1. Also there was a significant difference in median values of calcium BP between smoker control subjects and non-smoker control subjects (P <0.05), as shown in Tables 1 and 2 and Figure 1. Performing a regression analysis between calcium BP and smoking, represented by study groups, revealed a positive significant correlation, as shown in Figure 2. Table 1: Descriptive statistics of calcium BP in the three study groups Groups N Median Mean S.D. Min. Max. Smoker carcinoma 20 11.943 14.88 5.19 0.58 73.93 Smoker No carcinoma 20 4.897 5.884 3.09 1.36 11.63 Non-smoker No carcinoma 20 2.482 3.384 2.77 0.21 7.79 Kruskal Wallis H test = 20.331, d.f. = 2, p-value = <0.001 Fig.1: Comparison of Median values of Calcium BP among the three studied groups Table 2: Statistical differences among the study groups Groups Mann-Whitney U test d.f. p-value Group 1 vs. Group 2 77 1 <0.001 Group 1 vs. Group 3 49 1 <0.001 Group 2 vs. Group 3 123.5 1 <0.039 R=0.464, R2=0.215, P<0.001 Fig. 2: Regression analysis between smoking and salivary CB protein level in groups enrolled in the present study (1= non-smoker no carcinoma, 2= smoker no carcinoma, 3=smoker with carcinoma) J Bagh College Dentistry Vol. 28(2), June 2016 Salivary calcium binding Pedodontics, Orthodontics and Preventive Dentistry 151 DISCUSSION The results of the present showed an over- expression of salivary calcium binding protein in patients with OSCC in comparison with smoker and non-smoker control subjects with statistically highly significant differences. Over- expression of calcium binding protein in patients with OSCC was shown by several other studies, in agreement with the result of the present study (14-17). Also several studies showed over-expression of calcium binding protein in smoker patients without carcinoma (18,19). Tobacco smoking may induce the formation of reactive oxygen species that alter the function of rough endoplasmic reticulum, subsequently increasing the expression of several transcriptional factors that ultimately induces up-regulation of salivary proteomics including calcium binding proteins. The role of the calcium binding protein in OSCC is not fully understood, nevertheless Andrea Mueller et al. (20) suggested that the interaction among Calcium, p53 (a tumor suppressor protein) and calcium binding protein will ultimately lead to suppression of p53 and enhancement of cell growth and evasion of apoptosis. Thus salivary calcium binding proteins may have a key role as a non-invasive marker in the diagnosis and follow up of patients with OSCC. In conclusion, salivary calcium binding protein can be used as a non-invasive alternative method for the diagnosis and monitoring of OSCC. REFERENCES 1. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37(1 ):1-10 2. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003; 14(1): 47-62. 3. Sugimura T, Kumimoto H, Tohnai I, Fukui T,Matsuo K, Tsurusako S, et al. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 2006; 35(1):11-8. 4. Brennan JA, Boyle JO, KochWM, Goodman SN, Hruban RH, Eby YJ, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332(11): 712-7. 5. Cheng YL, Rees T, Wright J. A review of research on salivary biomarkers for oral cancer detection. Clinical and Translational Medicine 2014; 3: 3 6. Mittal S, Bansal V, Garg S, Atreja G, Bansal S. The diagnostic role of Saliva- A Review. J Clin Exp Dent 2011; 3(4): e314-20. 7. Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. Eur J Surg Oncol 2008; 34: 357-64. 8. Chen H, Xu C, Jin Q, Liu Z. S100 protein family in human cancer. Am J Cancer Res 2014; 4(2): 89-115. 9. Imazawa M, Hibi K, Fujitake S, Kodera Y, Ito Akiyama S, et al. S100A2 overexpression is frequently observed in esophageal squamous cell carcinoma. Anticancer Res 2005; 25: 1247-50. 10. Matsumoto K, Irie A, Satoh T, Ishii J, Iwabuchi K, Iwamura M, et al. Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer. Urology 2007; 70: 602-7. 11. McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ. The role of S100 genes in breast cancer progression. Tumour Biol 2011; 32: 441-50. 12. Ohuchida K, Mizumoto K, Miyasaka Y, Yu J, Cui L, Yamaguchi H, et al. Overexpression of S100 A2 in pancreatic cancer correlates with progression and poor prognosis. J Pathol 2007; 213: 275-82. 13. Tsai ST, Jin YT, Tsai WC, Wang ST, Lin YC, Chang MT, et al. S100A2. A potential marker for early recurrence in early-stage oral cancer. Oral Oncol 2005; 41: 349-57. 14. Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer. Clin Cancer Res 2006; 12(13): 3979-84. 15. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008; 14(19): 6246-52. 16. Balan JJ, Rao RS, Premalatha BR, Patil S. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study. J Contemp Dent Pract 2012; 13(5): 671-5. 17. Jessie K, Jayapalan JJ, Ong KC, Abdul Rahim ZH, Zain RM, Wong KT, Hashim OH. Aberrant proteins in the saliva of patients with oral squamous cell carcinoma. Electrophoresis 2013; 34(17): 2495-502. 18. Haigh BJ, Stewart KW, Whelan JRK, Barnett MPG, Smolenski GA, Wheeler TT. Alterations in the salivary proteome associated with periodontitis. J Clin Periodontol 2010; 37(3): 241-7. 19. Gonçalves LDR, Soares MR, Nogueira FCS, et al. Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J Proteomics 2010; 73(7): 1334-41. 20. Mueller A, Schafer BW, Hochli SM, Ferrari CWH, Weibel M, Makek M. The Calcium-binding Protein S100A2 Interacts with p53 and Modulates Its Transcriptional Activity. J Biol Chem 2005; 280: 29186-93.